Schroder Investment Management Group’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.43M Sell
79,091
-25,098
-24% -$1.12M ﹤0.01% 837
2026
Q1
$4.87M Buy
104,189
+20,447
+24% +$953K ﹤0.01% 786
2025
Q4
$4.08M Sell
83,742
-40,257
-32% -$2M ﹤0.01% 788
2025
Q3
$5.66M Buy
+123,999
New +$5.98M ﹤0.01% 753
2023
Q2
Sell
-5,279
Closed -$287K 1284
2023
Q1
$287K Buy
+5,279
New +$257K ﹤0.01% 1185
2016
Q1
Sell
-482
Closed -$21K 1216
2015
Q4
$21K Hold
482
﹤0.01% 1137
2015
Q3
$23K Hold
482
﹤0.01% 1126
2015
Q2
$24K Hold
482
﹤0.01% 1154
2015
Q1
$24K Hold
482
﹤0.01% 1184
2014
Q4
$22K Hold
482
﹤0.01% 1243
2014
Q3
$27.2K Buy
482
+104
+28% +$5.59K ﹤0.01% 1319
2014
Q2
$20.1K Hold
378
﹤0.01% 1305
2014
Q1
$19.8K Sell
378
-116
-23% -$5.87K ﹤0.01% 1339
2013
Q4
$26.5K Hold
494
﹤0.01% 1375
2013
Q3
$25K Hold
494
﹤0.01% 1386
2013
Q2
$25.4K Buy
+494
New +$26.3K ﹤0.01% 1362

Other funds holding SNY

Schroder Investment Management Group's SNY Position: Q2 2026 in Review

Schroder Investment Management Group reduced its Sanofi (SNY) stake by 24% in Q2 2026, selling an estimated $1.12M and leaving 79,091 shares worth $3.43M. The position accounts for ﹤0.01% of the portfolio, ranked #837.

Schroder Investment Management Group first reported a position in SNY in Q2 2013 and has held it in 16 quarters since. The position peaked at $5.66M in Q3 2025. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Schroder Investment Management Group held 79,091 shares of Sanofi worth $3.43M as of Q2 2026.
  • Schroder Investment Management Group sold 25,098 Sanofi shares in Q2 2026, an estimated $1.12M.
  • Sanofi made up ﹤0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #837 holding.
  • Schroder Investment Management Group first reported a position in Sanofi in Q2 2013 and has held it in 16 quarters since.
  • Schroder Investment Management Group's Sanofi position peaked at $5.66M in Q3 2025.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.